Our pharmaceutical product line is supported by strict control processes and international standards, ensuring efficacy, safety, and quality in every solution.

Cabazither

  • Active ingredient: Cabazitaxel.
  • Therapeutic area: Oncology.
  • Dosage form: Concentrate for solution for infusion.
  • Strength: 60 mg.
  • Presentation: Box x 01 vial.
  • Health registration no.: EE15394

Vorzemib

  • Active ingredient: Bortezomib.
  • Therapeutic area: Oncology.
  • Dosage form: Powder for solution for injection.
  • Strength: 3.50 mg.
  • Presentation: Box x 01 vial.
  • Health registration no.: EE15550

Oncotaxel Plus

  • Active ingredient: Docetaxel 80 mg.
  • Therapeutic area: Oncology.
  • Dosage form: Concentrate for solution for infusion.
  • Strength: Docetaxel 80 mg / 4 ml.
  • Presentation: Box x 01 vial.
  • Health registration no.: EE15496

Dasataxel

  • Active ingredient: Paclitaxel.
  • Therapeutic area: Oncology.
  • Dosage form: Concentrate for solution for infusion.
  • Strength: 30 mg.
  • Presentation: Box x 01 vial.
  • Health registration no.: EE15485

Dasataxel

  • Active ingredient: Paclitaxel.
  • Therapeutic area: Oncology.
  • Dosage form: Concentrate for solution for infusion.
  • Strength: 300 mg.
  • Presentation: Box x 01 vial.
  • Health registration no.: EE15549

Colotecan

  • Active ingredient: Irinotecan.
  • Therapeutic area: Oncology.
  • Dosage form: Concentrate for solution for infusion.
  • Strength: 100 mg.
  • Presentation: Box x 01 vial.
  • Health registration no.: EE15487

Trexmer 500 mg

  • Active ingredient: Pemetrexed.
  • Therapeutic area: Oncology.
  • Dosage form: Powder for concentrate for solution for infusion.
  • Strength: 500 mg.
  • Presentation: Box x 01 vial.
  • Health registration no.: EE15417

ventas@dspharmaperu.com.pe
+51 970 705 871
Jr. Francisco de Zela 2665, Lince, Lima. Perú.

Contacto